| ACTIVE
PHARMACEUTICAL INGREDIENTS |
ACTIVE
PHARMACEUTICAL INGREDIENTS
|
|
|
STATUS |
| Cetirizine dihydrochloride |
Antihistaminic |
21396 |
Filed |
| Erythromycin base |
Macrolides |
20137 |
Filed |
| Erythromycin estolate |
Macrolides |
20383 |
Filed |
| Erythromycin stearate |
Macrolides |
22061 |
Filed |
| Isoniazid |
Antitubercular |
21322 |
Filed |
| Losartan potassium |
Antihypertensive |
21911 |
Filed |
| Pyrazinamide |
Antitubercular |
15553 |
Filed |
| Valproic acid |
Antiepileptic |
21970 |
Filed |
| Zopiclone |
Sedative, Hypnotic |
15518 |
Approved |
PRODUCTS COMMERCIALLY AVAILABLE & DMF FILING IN PROCESS |
ACTIVE
PHARMACEUTICAL INGREDIENTS |
THERAPEUTIC
CATEGORY |
| Alendronate sodium |
Antiosteoporotic |
| Artesunate |
Antimalarial |
| Arteether |
Antimalarial |
| Artemether |
Antimalarial |
| Azithromycin |
Macrolides |
| Clarithromycin |
Macrolides |
| Dihydroartemisinin |
Antimalarial |
| Erythromycin ethylsuccinate |
Macrolides |
| Erythromycin oxime (intermediate) |
Macrolides |
| Flucytosine |
Antifungal |
| Hydroxyzine dihydrochloride |
Antihistaminic |
| Irbesartan |
Antihypertensive |
| Lumefantrine |
Antimalarial |
| Meclizine dihydrochloride |
Antihistaminic |
| Telmisartan |
Antihypertensive |
| Venlafaxine hydrochloride |
Antidepressant |
| Zoledronic acid |
Antiosteoporotic |
| INTERMEDIATES ON COMMERCIAL SCALE |
| Isonicotinic Acid |
| Pyrazinoic Acid |
PRODUCTS UNDER ADVANCED DEVELOPMENT |
INTERMEDIATES FOR ACTIVE
PHARMACEUTICAL INGREDIENTS |
THERAPEUTIC
CATEGORY |
PILOT PLANT SCALE |
| Clopidogrel bisulphate |
Antithrombotic |
| Divalproex sodium |
Antiepileptic |
| Eprosartan |
Antihypertensive |
| Eszopiclone |
hypnotic |
| Piperaquine |
Antimalarial |
| Valsartan |
Antihypertensive |
R&D SCALE |
| Atorvastatin calcium |
Lipid lowering agent |
| Desvenlafaxine succinate |
Antidepressant |
DEVELOPMENT |
| Famciclovir |
Antiretroviral |
| Ganciclovir |
Antiretroviral |
| Levocetirizine |
Antihistaminic |
| Valganciclovir |
Antiretroviral |
|
The
products protected by valid patents are not offered for sale in countries
where the sale of such products constitutes a patent
infringement. Also, the onus of patent applicability shall
remain with the importer only.
|
| |
| |